Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Family Practice · BANNING, CA · NPI 1528092459
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 784 | 276 |
| Levothyroxine Sodium | Levothyroxine Sodium | 562 | 167 |
| Gabapentin | Gabapentin | 498 | 121 |
| Losartan Potassium | Losartan Potassium | 495 | 161 |
| Lisinopril | Lisinopril | 358 | 104 |
| Amlodipine Besylate | Amlodipine Besylate | 314 | 110 |
| Omeprazole | Omeprazole | 297 | 92 |
| Alendronate Sodium | Alendronate Sodium | 283 | 80 |
| Metformin Hcl | Metformin Hcl | 245 | 87 |
| Diclofenac Sodium | Diclofenac Sodium | 244 | 95 |
| Hydrochlorothiazide | Hydrochlorothiazide | 205 | 71 |
| Eliquis | Apixaban | 186 | 49 |
| Pantoprazole Sodium | Pantoprazole Sodium | 141 | 43 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 135 | 37 |
| Tamsulosin Hcl | Tamsulosin Hcl | 133 | 38 |
| Trazodone Hcl | Trazodone Hcl | 129 | 32 |
| Metoprolol Tartrate | Metoprolol Tartrate | 127 | 44 |
| Januvia | Sitagliptin Phosphate | 126 | 33 |
| Metoprolol Succinate | Metoprolol Succinate | 126 | 45 |
| Furosemide | Furosemide | 124 | 42 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 120 | 49 |
| Potassium Chloride | Potassium Chloride | 119 | 41 |
| Escitalopram Oxalate | Escitalopram Oxalate | 117 | 32 |
| Carvedilol | Carvedilol | 111 | 32 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 111 | 89 |
| Synthroid | Levothyroxine Sodium | 109 | 39 |
| Atenolol | Atenolol | 103 | 36 |
| Celecoxib | Celecoxib | 89 | 27 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 85 | 40 |
| Simvastatin | Simvastatin | 85 | 26 |
| Duloxetine Hcl | Duloxetine Hcl | 83 | 24 |
| Fluticasone Propionate | Fluticasone Propionate | 83 | 31 |
| Clopidogrel | Clopidogrel Bisulfate | 82 | 29 |
| Memantine Hcl | Memantine Hcl | 79 | 26 |
| Ozempic | Semaglutide | 63 | 17 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 58 | 21 |
| Glipizide | Glipizide | 57 | 21 |
| Oxybutynin Chloride | Oxybutynin Chloride | 56 | 17 |
| Pravastatin Sodium | Pravastatin Sodium | 53 | 15 |
| Ezetimibe | Ezetimibe | 50 | 21 |
| Ibuprofen | Ibuprofen | 49 | 26 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 48 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 47 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 44 | 32 |
| Sertraline Hcl | Sertraline Hcl | 42 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 41 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 40 | 11 |
| Prednisone | Prednisone | 40 | 18 |
| Meloxicam | Meloxicam | 39 | 13 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 38 | 19 |
| Famotidine | Famotidine | 38 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 38 | 12 |
| Lidocaine | Lidocaine | 37 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 36 | 13 |
| Benazepril Hcl | Benazepril Hcl | 34 | 14 |
| Clotrimazole | Clotrimazole | 34 | 20 |
| Nitroglycerin | Nitroglycerin | 34 | 17 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 33 | 20 |
| Methylprednisolone | Methylprednisolone | 33 | 31 |
| Solifenacin Succinate | Solifenacin Succinate | 32 | suppressed |
| Allopurinol | Allopurinol | 31 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 31 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 31 | 22 |
| Spironolactone | Spironolactone | 31 | suppressed |
| Jardiance | Empagliflozin | 30 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 29 | 19 |
| Finasteride | Finasteride | 28 | suppressed |
| Digoxin | Digoxin | 27 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 27 | suppressed |
| Mirtazapine | Mirtazapine | 27 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 26 | 13 |
| Nortriptyline Hcl | Nortriptyline Hcl | 26 | suppressed |
| Azithromycin | Azithromycin | 25 | 24 |
| Citalopram Hbr | Citalopram Hydrobromide | 25 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 25 | suppressed |
| Glimepiride | Glimepiride | 25 | suppressed |
| Pregabalin | Pregabalin | 25 | suppressed |
| Valsartan | Valsartan | 25 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 24 | 11 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 24 | suppressed |
| Xarelto | Rivaroxaban | 24 | suppressed |
| Baclofen | Baclofen | 23 | suppressed |
| Lovastatin | Lovastatin | 23 | 11 |
| Acyclovir | Acyclovir | 22 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 22 | suppressed |
| Nifedipine Er | Nifedipine | 22 | suppressed |
| Gemfibrozil | Gemfibrozil | 21 | suppressed |
| Glipizide Er | Glipizide | 21 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 20 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 20 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 20 | suppressed |
| Trulicity | Dulaglutide | 20 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 19 | suppressed |
| Myrbetriq | Mirabegron | 19 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 19 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Creon | Lipase/Protease/Amylase | 18 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Folic Acid | Folic Acid | 18 | suppressed |
| Bupropion Xl | Bupropion Hcl | 17 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 17 | suppressed |
| Lorazepam | Lorazepam | 17 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 17 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 16 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 15 | suppressed |
| Irbesartan | Irbesartan | 15 | suppressed |
| Metronidazole | Metronidazole | 15 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 15 | suppressed |
| Topiramate | Topiramate | 15 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 15 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 14 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 14 | 14 |
| Potassium Citrate Er | Potassium Citrate | 14 | suppressed |
| Telmisartan | Telmisartan | 14 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 13 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Prevacid | Lansoprazole | 12 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 12 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 12 | suppressed |
| Alprazolam | Alprazolam | 11 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 11 | 11 |
| Azelastine Hcl | Azelastine Hcl | 11 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 11 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 11 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 11 | suppressed |
| Pentoxifylline | Pentoxifylline | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 11 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error